Artículos por temáticas

Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward

Panza F, Solfrizzi V, Imbimbo BP, Tortelli R, Santamato A, Logroscino G.

Expert Rev Clin Immunol. 2014 Mar;10(3):405-19. doi: 10.1586/1744666X.2014.883921. Epub 2014 Feb 4.

[Clinical observation of Alzheimer's disease treated with acupuncture]

Gu W, Jin XX, Zhang YJ, Li ZJ, Kong Y.

Zhongguo Zhen Jiu. 2014 Dec;34(12):1156-60.

Rivastigmine transdermal patch and physical exercises for Alzheimer's disease: a randomized clinical trial

Aguiar P, Monteiro L, Feres A, Gomes I, Melo A.

Curr Alzheimer Res. 2014;11(6):532-7. doi: 10.2174/1567205011666140618102224.

[Violence against disabled persons]

Schulte-Wissermann H.

Kinderkrankenschwester. 2014 Jun;33(6):208.

From dementia fearful to dementia friendly: be a champion in your community

Lin SY, Becker M, Belza B.

J Gerontol Nurs. 2014 Dec;40(12):3-5. doi: 10.3928/00989134-20141114-01.

Curcumin as a therapeutic agent in dementia: a mini systematic review of human studies

Brondino N, Re S, Boldrini A, Cuccomarino A, Lanati N, Barale F, Politi P.

ScientificWorldJournal. 2014 Jan 22;2014:174282. doi: 10.1155/2014/174282. eCollection 2014.

The effect of funding sources on donepezil randomised controlled trial outcome: a meta-analysis

Killin LO, Russ TC, Starr JM, Abrahams S, Della Sala S.

BMJ Open. 2014 Apr 7;4(4):e004083. doi: 10.1136/bmjopen-2013-004083.

The complex actions of statins in brain and their relevance for Alzheimer's disease treatment: an analytical review

Mendoza-Oliva A, Zepeda A, Arias C.

Curr Alzheimer Res. 2014;11(9):817-33.

Drugs developed for treatment of diabetes show protective effects in Alzheimer's and Parkinson's diseases

Hölscher C.

Sheng Li Xue Bao. 2014 Oct 25;66(5):497-510.

[Case discussion as a part of nursing care planning: planning nursing care is team work]

Werner S.

Pflege Z. 2014 Apr;67(4):216-9.

[Long-term antipsychotics for patients with dementia - discontinue or continue treatment?]

Renard D, de Pélichy E, von Elm E.

Praxis (Bern 1994). 2014 Jan 15;103(2):109-10. doi: 10.1024/1661-8157/a001543.

Phytomedicines as potential inhibitors of β amyloid aggregation: significance to Alzheimer's disease

Kumar NS, Nisha N.

Chin J Nat Med. 2014 Nov;12(11):801-18. doi: 10.1016/S1875-5364(14)60122-9.

Implications of some selected flavonoids towards Alzheimer's disease with the emphasis on cholinesterase inhibition and their bioproduction by metabolic engineering

Orhan IE.

Curr Pharm Biotechnol. 2014;15(4):352-61. doi: 10.2174/1389201015666140813123204.

Auditory hallucinations associated with nitrofurantoin use: case report and review of the literature

Štuhec M.

Wien Klin Wochenschr. 2014 Sep;126(17-18):549-52. doi: 10.1007/s00508-014-0577-6. Epub 2014 Aug 15.

Inhibition of early upstream events in prodromal Alzheimer's disease by use of targeted antioxidants

Prasad KN, Bondy SC.

Curr Aging Sci. 2014;7(2):77-90. doi: 10.2174/1874609807666140804115633.